TIDMDPH
RNS Number : 2365U
Dechra Pharmaceuticals PLC
20 October 2017
Date: 20 October 2017
Dechra(R) Pharmaceuticals PLC
Results of Annual General Meeting (AGM)
AGM Meeting Date: 1pm on 20 October 2017
Issued Share Capital at meeting date: 93,415,750
Number of shareholders in attendance: 12
All resolutions were passed on a show of hands.
Details of the proxy voting instructions lodged prior to the AGM
are set out below:
Resolution (No. Total For Total Against Withheld
as noted on proxy (1) (2)
form)
-------------------------------------- ------------------- ------------------ ----------
No. of % No. of % No. of
votes of votes of votes
vote vote
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 1:
To receive the
accounts, the Strategic
Report, the Directors'
Report and the
Auditor's Report 69,787,352 94.83 3,801,367 5.17 176,986
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 2:
To receive and
approve the Directors'
Remuneration Report 66,111,495 94.18 4,086,647 5.82 3,567,713
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 3:
To receive and
approve the Directors'
Remuneration Policy 72,932,631 98.88 823,955 1.12 8,619
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 4:
To declare a final
dividend 73,764,546 100 0 0.00 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 5:
To elect Richard
Cotton 72,195,608 97.87 1,568,938 2.13 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 6:
To elect Lawson
Macartney 73,401,877 99.51 361,469 0.49 1,859
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 7:
To re-elect Tony
Rice 66,992,715 92.48 5,448,270 7.52 1,324,220
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 8:
To re-elect Ian
Page 72,285,663 98.00 1,478,883 2.00 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 9:
To re-elect Anthony
Griffin 72,279,341 97.99 1,485,205 2.01 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 10:
To re-elect Julian
Heslop 73,500,858 99.64 263,688 0.36 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 11:
To re-elect Ishbel
Macpherson 73,144,501 99.16 620,045 0.84 659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 12:
To reappoint PricewaterhouseCoopers
as external auditor
of the Company 73,756,778 99.99 7,318 0.01 1,109
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 13:
To authorise the
Audit Committee
to determine the
remuneration of
the external auditor 73,763,069 100 1,027 0.00 1,109
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 14:
To authorise the
Directors to allot
shares to specific
limits 69,568,791 94.32 4,191,805 5.68 4,609
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 15:
To disapply the
pre-emption rights 72,858,327 98.78 903,219 1.22 3,659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 16:
To disapply additional
pre-emption rights 67,395,228 91.37 6,366,318 8.63 3,659
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 17:
To authorise the
Company to purchase
its own shares 72,978,224 99.07 685,466 0.93 101,515
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 18:
To call general
meetings (other
than an AGM) on
not less than 14
clear days' notice 71,828,591 97.38 1,935,505 2.62 1,109
-------------------------------------- ----------- ------ ---------- ------ ----------
Resolution 19:
(a) To approve
the rules of the
LTIP 2017; and
(b) To authorise
the Directors to
adopt further schemes
based on the LTIP
2017 70,433,043 95.49 3,328,963 4.51 3,199
-------------------------------------- ----------- ------ ---------- ------ ----------
Notes
1. Includes discretionary votes.
2. A "vote withheld" is not a vote in law and is not counted in
the calculation of the proportion of votes "For" and "Against" a
resolution.
3. Resolutions 1 to 14 and Resolution 19 were ordinary
resolutions, requiring more than 50% of shareholder votes to be
"for" the resolutions.
4. Resolutions 15 to 18 were special resolutions, requiring more
than 75% of shareholder votes to be "for" the resolutions.
5. Votes tendered in respect of 73,765,205 shares representing
78.96% of the issued share capital.
In accordance with Listing Rule 9.6.2R, a copy of the
resolutions passed as special business at the AGM have been
submitted to the National Storage Mechanism and will shortly be
available for inspection at www.morningstar.co.uk/uk/nsm.
For further information
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. The majority of Dechra's
products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to
treat medical conditions for which there is no other effective
solution or have a clinical or dosing advantage over competitor
products. For more information, please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGFMMZGFGDGNZM
(END) Dow Jones Newswires
October 20, 2017 09:35 ET (13:35 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024